STOCK TITAN

Ultragenyx to Participate in Investor Conferences in December

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Ultragenyx Pharmaceutical (NASDAQ: RARE) has announced its participation in three major investor conferences in December 2024. The company will attend Citi's 2024 Global Healthcare Conference in Miami, the 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, and Piper Sandler's 36th Annual Healthcare Conference in New York.

Key executives including CEO Emil Kakkis, CFO Howard Horn, and CMO Eric Crombez will participate in fireside chats and host one-on-one meetings across these events. Live and archived webcasts will be available on the company's investor relations website.

Ultragenyx Pharmaceutical (NASDAQ: RARE) ha annunciato la sua partecipazione a tre importanti conferenze per investitori a dicembre 2024. L'azienda parteciperà alla Citi's 2024 Global Healthcare Conference a Miami, alla 7th Annual Evercore ISI HealthCONx Conference a Coral Gables, e alla 36th Annual Healthcare Conference di Piper Sandler a New York.

Dirigenti chiave, tra cui il CEO Emil Kakkis, il CFO Howard Horn e il CMO Eric Crombez, parteciperanno a discussioni informali e ospiteranno incontri one-on-one durante questi eventi. Saranno disponibili webcast in diretta e registrati sul sito web delle relazioni con gli investitori dell'azienda.

Ultragenyx Pharmaceutical (NASDAQ: RARE) ha anunciado su participación en tres importantes conferencias para inversores en diciembre de 2024. La compañía asistirá a la Citi's 2024 Global Healthcare Conference en Miami, a la 7th Annual Evercore ISI HealthCONx Conference en Coral Gables, y a la 36th Annual Healthcare Conference de Piper Sandler en Nueva York.

Ejecutivos clave, incluyendo al CEO Emil Kakkis, al CFO Howard Horn y al CMO Eric Crombez, participarán en charlas informales y llevarán a cabo reuniones uno a uno durante estos eventos. Habrá webcasts en vivo y grabados disponibles en el sitio web de relaciones con inversores de la empresa.

울트라제닉스 제약 (NASDAQ: RARE)는 2024년 12월에 열리는 세 가지 주요 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 마이애미에서 열리는 Citi's 2024 Global Healthcare Conference, 코럴 게이블스에서 열리는 7th Annual Evercore ISI HealthCONx Conference, 그리고 뉴욕에서 열리는 Piper Sandler's 36th Annual Healthcare Conference에 참석할 예정입니다.

CEO EMIL KAKKIS, CFO HOWARD HORN, CMO ERIC CROMBEZ를 포함한 주요 경영진이 대화와 1:1 미팅을 진행할 것입니다. 회사의 투자자 관계 웹사이트에서 실시간 및 기록된 웹캐스트를 확인할 수 있습니다.

Ultragenyx Pharmaceutical (NASDAQ: RARE) a annoncé sa participation à trois grandes conférences pour investisseurs en décembre 2024. L'entreprise assistera à la Citi's 2024 Global Healthcare Conference à Miami, à la 7th Annual Evercore ISI HealthCONx Conference à Coral Gables, et à la 36th Annual Healthcare Conference de Piper Sandler à New York.

Des dirigeants clés, notamment le PDG Emil Kakkis, le directeur financier Howard Horn et le directeur médical Eric Crombez, participeront à des discussions informelles et organiseront des rencontres individuelles lors de ces événements. Des webcasts en direct et enregistrés seront disponibles sur le site web des relations avec les investisseurs de la société.

Ultragenyx Pharmaceutical (NASDAQ: RARE) hat seine Teilnahme an drei bedeutenden Investorenkonferenzen im Dezember 2024 bekannt gegeben. Das Unternehmen wird an der Citi's 2024 Global Healthcare Conference in Miami, der 7th Annual Evercore ISI HealthCONx Conference in Coral Gables und der 36th Annual Healthcare Conference von Piper Sandler in New York teilnehmen.

Wichtige Führungskräfte, darunter CEO Emil Kakkis, CFO Howard Horn und CMO Eric Crombez, werden an informellen Gesprächen teilnehmen und Einzelgespräche während dieser Veranstaltungen führen. Live- und archivierte Webcasts werden auf der Investor Relations-Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

NOVATO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced participation in three upcoming investor conferences.

Citi’s 2024 Global Healthcare Conference (Miami, FL)

  • Tuesday, December 3, 2024, Emil Kakkis, M.D., Ph.D., CEO and President and Howard Horn, Chief Financial Officer, will participate in a fireside chat and host 1x1 meetings.

7th Annual Evercore ISI HealthCONx Conference (Coral Gables, FL)

  • Wednesday, December 4, 2024, Emil Kakkis and Howard Horn will participate in a fireside chat and host 1x1 meetings.

Piper Sandler’s 36th Annual Healthcare Conference (New York, NY)

  • Thursday, December 5, 2024, Eric Crombez, M.D., Chief Medical Officer and Howard Horn will participate in a fireside chat and host 1x1 meetings.

The live and archived webcast of the fireside chats will be accessible from the company’s website at https://ir.ultragenyx.com/events-presentations.

About Ultragenyx Pharmaceutical Inc.

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.

Contacts – Ultragenyx Pharmaceutical, Inc.

Investors
Joshua Higa
ir@ultragenyx.com


FAQ

Which investor conferences will Ultragenyx (RARE) attend in December 2024?

Ultragenyx will attend three conferences: Citi's Global Healthcare Conference in Miami (Dec 3), Evercore ISI HealthCONx Conference in Coral Gables (Dec 4), and Piper Sandler's Healthcare Conference in New York (Dec 5).

Who will represent Ultragenyx (RARE) at the December 2024 investor conferences?

Different executives will represent Ultragenyx: CEO Emil Kakkis and CFO Howard Horn will attend Citi's and Evercore's conferences, while CMO Eric Crombez and CFO Howard Horn will attend the Piper Sandler conference.

Where can investors watch Ultragenyx's (RARE) December 2024 conference presentations?

Investors can access live and archived webcasts of the fireside chats through Ultragenyx's investor relations website at https://ir.ultragenyx.com/events-presentations.

Ultragenyx Pharmaceutical Inc.

NASDAQ:RARE

RARE Rankings

RARE Latest News

RARE Stock Data

4.02B
88.07M
3.62%
97.44%
3.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO